22. January 2020
René Zünd, former majority shareholder and Chairman of the Board of Directors of the Zünd Group, is delighted with the successful succession arrangements: “With Verium at our side, we have an experienced and financially strong partner with which to set the course for successful development of our company.” René Zünd will retain a significant stake in the company and continue to be involved in the enterprise, thus ensuring continuity and a smooth transition.
As previously, the team including Managing Director Oscar Turienzo and Head of Production Ernst Pienz will continue to bear responsibility as before and will also take a financial interest in the company as part of the transaction. “The Zünd Group will continue to differentiate itself in the future through unparalleled quality, a strong customer focus, and technological expertise,” says Oscar Turienzo. “We are very pleased that we have been able to recruit Verium as a strong partner and that René Zünd will remain actively involved in the company with his knowledge and experience – all of this represents an excellent situation for the Zünd Group going forward. Together we want to develop the company on a sustainable basis and expand and further optimize the range of services we offer to our customers. Verium will be contributing Damian Stricker and George Merk to serve on the Board of Directors of the company. “The Zünd Group is a hidden champion with a strong market position, motivated employees, and a coherent growth strategy,” says Damian Stricker, the new Chairman of the Board of Directors of the Zünd Group. “The continuing trend towards minimally invasive surgery using robots in particular will open up further potential for the company. We are convinced that we will be able to exploit the existing
market opportunities together with the management and René Zünd. Christian Velez will be joining Damian Stricker and George Merk on the Board of Directors. He has many years of industry experience and is the founder and CEO of Exalos, which specializes in light sources for complex applications.
Zünd Precision Optics Ltd, founded in 1968, is one of the world’s leading manufacturers of optical components in the micrometer range, offering high-quality glass prisms, plano optics, and cementing solutions that are used primarily in medical technology (endoscopy) but also in industry,
metrology, defense technology, aerospace, and telecommunications. Optivac is a specialist in the coating of optical components. PVD and IAD technology is used to produce antireflective, filter, mirror, and beam-splitter coatings. The Zünd Group currently employs roughly 65 people and has a state-of-the-art production facility in Diepoldsau.
Verium is an independent multi-family office that manages investments in small and medium-sized enterprises in Germany, Austria, and Switzerland for its investors. In the past, Verium has invested in ventures including Home Instead, basefit.ch, Christ & Heiri, Toradex, Ceposa, Quickmail, Mobil in Time/S&G, and DSwiss. Verium was advised on this transaction by Wenger & Vieli (legal issues), Ernst & Young (finance and tax matters), and Alvarez & Marsal (market research). The sellers were accompanied by UBS (M&A), Bratschi (legal issues), and Unit Consulting (tax matters).